Compounds > bexarotene

Page last updated: 2024-08-25

bexarotene and t0901317

bexarotene has been researched along with t0901317 in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (83.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Abad, MC; Askari, HB; De, D; Gaul, MD; Geisler, JG; Kasturi, J; Kemmerer, M; Kim, AJ; Lenhard, JM; Lin, L; Liu, J; O'Neill, JC; Patch, RJ; Player, MR; Rentzeperis, D; Searle, LL; Zhu, X	1
Achenbach, J; Heitel, P; Merk, D; Moser, D; Proschak, E	1
Gellrich, L; Heering, J; Kaiser, A; Kalinowsky, L; Kilu, W; Merk, D; Ohrndorf, J; Pollinger, J; Proschak, E; Schierle, S; Schmidt, J	1
Chaikuad, A; Gellrich, L; Heitel, P; Kaiser, A; Knapp, S; Merk, D; Ohrndorf, J; Pollinger, J; Schierle, S	1
Fujihara, M; Ito, S; Kakuta, H; Kawasaki, M; Makishima, M; Motoyama, T; Nakano, S; Takamura, Y; Watanabe, M; Yamada, S	1
Carroll, M; Glantz, ST; Kasner, MT; Sanchez, PV; Scotland, S	1

Other Studies

6 other study(ies) available for bexarotene and t0901317

Article	Year
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents. Journal of medicinal chemistry, 2011, Feb-10, Volume: 54, Issue:3 Topics: Administration, Oral; Animals; Binding, Competitive; Biological Availability; Crystallography, X-Ray; Diabetes Mellitus; Dogs; ERRalpha Estrogen-Related Receptor; Ethers; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Ligands; Macaca fascicularis; Male; Mice; Mice, Knockout; Models, Molecular; Molecular Structure; Obesity; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Thiazolidinediones; Triglycerides	2011
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators. Bioorganic & medicinal chemistry letters, 2017, 03-01, Volume: 27, Issue:5 Topics: Alitretinoin; Animals; Bexarotene; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Liver X Receptors; Mice; Tetrahydronaphthalenes; Tretinoin	2017
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation. Journal of medicinal chemistry, 2019, 02-28, Volume: 62, Issue:4 Topics: Animals; HEK293 Cells; Hep G2 Cells; Humans; Male; Mice, Inbred C57BL; Microsomes, Liver; Molecular Structure; Peroxisome Proliferator-Activated Receptors; Pyrimidines; Rats; Retinoid X Receptors; Structure-Activity Relationship	2019
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences. ACS medicinal chemistry letters, 2019, Sep-12, Volume: 10, Issue:9 Topics:	2019
Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers. Journal of medicinal chemistry, 2021, 01-14, Volume: 64, Issue:1 Topics: Allosteric Regulation; Circular Dichroism; Crystallography, X-Ray; Dimerization; Ligands; Retinoid X Receptors	2021
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors. Leukemia, 2014, Volume: 28, Issue:4 Topics: Bexarotene; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cell Line, Tumor; Humans; Hydrocarbons, Fluorinated; Leukemia, Myeloid, Acute; Liver X Receptors; Nicotinic Acids; Orphan Nuclear Receptors; Proto-Oncogene Proteins; Retinoid X Receptors; Sulfonamides; Tetrahydronaphthalenes; Trans-Activators; Tretinoin	2014